| # | Drug | Count |
|---|---|---|
| 0 | OMALIZUMAB | 827 |
| 1 | ALBUTEROL SULFATE | 735 |
| 2 | PREDNISONE | 588 |
| 3 | MONTELUKAST SODIUM | 555 |
| 4 | TIOTROPIUM BROMIDE | 481 |
| 5 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 365 |
| 6 | MEPOLIZUMAB | 316 |
| 7 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 292 |
| 8 | CICLESONIDE | 271 |
| 9 | MONTELUKAST | 271 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EDETATE CALCIUM DISODIUM | 29 | 0.7250 |
| 1 | AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE | 10 | 0.0855 |
| 2 | CICLESONIDE | 271 | 0.0197 |
| 3 | GLYCOPYRROLATE | 101 | 0.0179 |
| 4 | TERBUTALINE SULFATE | 29 | 0.0158 |
| 5 | SULFACETAMIDE SODIUM | 6 | 0.0122 |
| 6 | CHOLESTERINUM | 11 | 0.0098 |
| 7 | OMALIZUMAB | 827 | 0.0095 |
| 8 | AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | 32 | 0.0077 |
| 9 | MEPOLIZUMAB | 316 | 0.0063 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 963 |
| 1 | Anti-IgE [EPC] | 827 |
| 2 | Interleukin-5 Antagonist [EPC] | 317 |
| 3 | Proton Pump Inhibitor [EPC] | 239 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 185 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 126 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 125 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 123 |
| 8 | Vitamin C [EPC] | 110 |
| 9 | Provitamin D2 Compound [EPC] | 109 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 317 | 0.4608 |
| 1 | Human C1 Esterase Inhibitor [EPC] | 50 | 0.0128 |
| 2 | Anti-IgE [EPC] | 827 | 0.0095 |
| 3 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 4 | Diagnostic Dye [EPC] | 4 | 0.0062 |
| 5 | Provitamin D2 Compound [EPC] | 109 | 0.0037 |
| 6 | Leukotriene Receptor Antagonist [EPC] | 88 | 0.0030 |
| 7 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 43 | 0.0020 |
| 8 | Anthelmintic [EPC] | 5 | 0.0017 |
| 9 | alpha-Glucosidase Inhibitor [EPC] | 8 | 0.0016 |